Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming

Background. Sipuleucel T, an autologous cell-based vaccine targeting prostatic acid phosphatase (PAP), has demonstrated efficacy for the treatment of advanced prostate cancer. DNA vaccines encoding PAP and live attenuated Listeria vaccines have entered clinical trials for patients with prostate canc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncoimmunology
Main Authors: Johnson, Laura E., Brockstedt, Dirk, Leong, Meredith, Lauer, Peter, Theisen, Erin, Sauer, John-Demian, McNeel, Douglas G.
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136874/
https://ncbi.nlm.nih.gov/pubmed/30221049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1456603
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker